These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 8700037)

  • 1. Analytic representation of the dose from a 32P-coated stent.
    Prestwich WV
    Med Phys; 1996 Jan; 23(1):9-13. PubMed ID: 8700037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation dose from a phosphorous-32 impregnated wire mesh vascular stent.
    Janicki C; Duggan DM; Coffey CW; Fischell DR; Fischell TA
    Med Phys; 1997 Mar; 24(3):437-45. PubMed ID: 9089595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-absorption correction for 32P, 198Au and 188Re stents: dose point kernel calculations versus Monte Carlo.
    Reynaert N; Häfeli UO
    Med Phys; 2001 Sep; 28(9):1883-97. PubMed ID: 11585219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose distribution for a 32P-impregnated coronary stent: comparison of theoretical calculations and measurements with radiochromic film.
    Duggan DM; Coffey CW; Levit S
    Int J Radiat Oncol Biol Phys; 1998 Feb; 40(3):713-20. PubMed ID: 9486624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monte Carlo calculations of dose distributions around 32P and 198Au stents for intravascular brachytherapy.
    Reynaert N; Verhaegen F; Taeymans Y; Van Eijkeren M; Thierens H
    Med Phys; 1999 Aug; 26(8):1484-91. PubMed ID: 10501047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advantages and limitations of radioactive stents.
    Hehrlein C; Kübler W
    Semin Interv Cardiol; 1997 Jun; 2(2):109-13. PubMed ID: 9546990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dose distribution produced by a 32P-coated stent.
    Prestwich WV; Kennett TJ; Kus FW
    Med Phys; 1995 Mar; 22(3):313-20. PubMed ID: 7596321
    [No Abstract]   [Full Text] [Related]  

  • 8. The impact of stent design and delivery upon the long-term efficacy of radioisotope stents.
    Fischell TA; Hehrlein C; Fischell RE; Fischell DR
    J Invasive Cardiol; 2000 Mar; 12(3):162-7. PubMed ID: 10731287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetry of beta emitting radionuclides for use in balloon angioplasty.
    Fox RA
    Australas Phys Eng Sci Med; 1997 Sep; 20(3):139-46. PubMed ID: 9409014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comment on "Self-absorption correction for 32P, 198Au, and 188Re stents: dose point kernel calculations versus Monte Carlo".
    Janicki C
    Med Phys; 2002 Feb; 29(2):260-1. PubMed ID: 11865998
    [No Abstract]   [Full Text] [Related]  

  • 11. A novel balloon angioplasty catheter impregnated with beta-particle emitting radioisotopes for vascular brachytherapy to prevent restenosis; first in vivo results.
    Hehrlein C; Kovacs A; Wolf GK; Yue N; Nath R
    Eur Heart J; 2000 Dec; 21(24):2056-62. PubMed ID: 11102256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental determination of 32P dose backscatter factors at and near soft-tissue boundaries.
    Nunes J; Prestwich WV; Kwok CS
    Med Phys; 1993; 20(1):223-31. PubMed ID: 8455504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta radiation and inhibition of recanalization after coil embolization of canine arteries and experimental aneurysms: how should radiation be delivered?
    Raymond J; Leblanc P; Morel F; Salazkin I; Gevry G; Roorda S
    Stroke; 2003 May; 34(5):1262-8. PubMed ID: 12702839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The investigation of 32P wire for catheter-based endovascular irradiation.
    Xu Z; Reinstein LE; Yang G; Pai S; Gluckman G; Almond PR
    Med Phys; 1997 Nov; 24(11):1788-92. PubMed ID: 9394287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioactive stents.
    Fischell TA
    Semin Interv Cardiol; 1998 Jun; 3(2):51-6. PubMed ID: 10212495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. European high-activity (32)P radioactive stent experience.
    Albiero R; Colombo A
    J Invasive Cardiol; 2000 Aug; 12(8):416-21. PubMed ID: 10953106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-particle emission from stent wire.
    Crocker I; McGinley P; Waksman R; Robinson K; King SB
    Circulation; 1995 Sep; 92(5):1353-4. PubMed ID: 7648690
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of tissue inhomogeneity on beta dose distribution of 32P.
    Kwok CS; Irfan M; Woo MK; Prestwich WV
    Med Phys; 1987; 14(1):98-104. PubMed ID: 3104745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and angiographical follow-up after implantation of a 6--12 microCi radioactive stent in patients with coronary artery disease.
    Wardeh AJ; Knook AH; Kay IP; Sabaté M; Coen VL; Foley DP; Hamburger JN; Levendag PC; van der Giessen WJ; Serruys PW
    Eur Heart J; 2001 Apr; 22(8):669-75. PubMed ID: 11286524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of model of renarrowing after beta radiation for in-stent restenosis.
    Witkowski A; Chmielak Z; Kalińczuk Ł; Pregowski J; Kepka C; Kruk M; Przyłuski J; Łyczek J; Bulski W; Kawczyńska M; Kulik A; Owczarczyk J; Ruzyłło W
    Int J Cardiol; 2006 Feb; 107(2):247-53. PubMed ID: 16412805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.